Stay updated on Talimogene Laherparepvec and Nivolumab Combination Clinical Trial

Sign up to get notified when there's something new on the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    No significant changes detected.
    Difference
    0.2%
    Check dated 2025-10-20T14:00:02.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    No significant changes were detected. The page content remains the same.
    Difference
    0.2%
    Check dated 2025-10-13T08:51:28.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Major changes include a platform-wide operating status notice due to funding lapses and an update from v3.1.0 to v3.2.0; two medical terms were removed from the content.
    Difference
    2%
    Check dated 2025-10-06T05:41:25.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Core content updates: new and renamed medical terms (Extramammary Paget disease, Microcystic adnexal carcinoma, Carcinoma, Basal Cell) are added; an older term (Extramammary paget disease) and a related term (Malignant syringoma) are removed; revision bumped from v3.0.2 to v3.1.0.
    Difference
    0.4%
    Check dated 2025-09-29T03:08:22.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    No significant changes detected.
    Difference
    0.2%
    Check dated 2025-09-21T22:41:36.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.3%
    Check dated 2025-09-14T19:17:36.000Z thumbnail image

Stay in the know with updates to Talimogene Laherparepvec and Nivolumab Combination Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page.